Cut the Cost of Doing Business

Past Weekly Updates

• October 17, 2011
• October 10, 2011
• October 3, 2011

Recommended Events 

January 23 - 24, 2012

Computer History Museum, Silicon Valley 

RSVP Now 

16 Days Left

Reserve Your Seat to Interface With Emerging Southern California-Based Biotech and Medical Device Companies

• Sponsorship & Exhibit Opportunities Available 
• Click Here for Conference Agenda

The following companies will be presenting:

• California Stem Cell Inc. (Irvine): Production of high purity human cells for therapeutic development and clinical application 
• ImmunoCellular Therapeutics (Woodland Hills): Immunotherapeutics for brain cancer
• Kythera Biopharmaceuticals (Calabasas): Novel prescription products for the aesthetic market
• LyoTip, Inc. (Camarillo): Lyophilized drug delivery
• MindFrame (Irvine): Device to capture and retrieve clots and restore blood flow in the cerebral vasculature of patients suffering from an acute ischemic stroke
• MiniPumps, LLC (Pasadena): Pumps for subcutaneous drug delivery
• Neumedicines (Pasadena): Protein therapeutics that address unmet clinical and societal needs in the fields of oncology, hematology, and immunology)
• Resolve Therapeutics (Los Angeles): Peptides to treat autoimmune diseases 

...and many more. Click here to see an updated list of companies selected to date 

Thanks to SoCalBio Partners

KPMG Research Indicates Returns on Drug R&D Nearly Halved Between 1990 and 2010

Back in 1990, the world's 50 leading drugmakers generated an average post-tax return on R&D expenditure of around 17 percent, yet by last year this had dwindled to little more than 10 percent, according to KPMG calculations... Read more

Layoffs May Sow Seeds for Life Science Startups

Deborah Crowe of the Los Angeles Business Journal contends that layoffs at Amgen could prove a shot in the arm to life science companies looking to staff up... Read more (Subscription required)

• See Reuter's story on Amgen's layoffs

C3 Jian Relocates to Marina del Rey

C3 Jian, Inc. announced that it has signed a long term lease to move its U.S. headquarter and R&D operations to Marina del Rey, California. The Company is currently located in Inglewood, California. C3 Jian will occupy a 35,000 sq. foot biotechnology facility located in the Marina Business Center. The building is fully built-out as a first class biotechnology research and development facility, with GMP manufacturing capacity. C3 Jian expects to complete some relatively minor tenant improvements to match its research and development requirements, with the goal of occupying the new facility in January 2012 ... Read more

Aeolus Pharmaceuticals Announces NIH Grant Award to Develop a Treatment Against Nerve Agent Exposure

"We are pleased to see the expansion of the research and development of AEOL 10150 as a broad spectrum medical countermeasure, and are grateful for the support that NIH CounterACT provides for the development of this promising compound. With this project, the US Government is now funding research and testing of AEOL 10150 in five MCM indications," stated John L. McManus, President and Chief Executive Officer of the Mission Viejo-based Aeolus Pharmaceuticals, Inc. ... Read more

Masimo Launches Radical-7 Pulse Oximeter in the US and Europe

The Irvine-based Masimo received FDA clearance and CE Mark of approval for the Radical-7 non-invasive pulse oximeter with rainbow Acoustic Monitoring technology that provides continuous readings of the acoustic respiration rate (RRa) waveform and measurements. A new feature on the system, not yet approved by the FDA, called In Vivo Adjustment, allows clinicians to calibrate the device to individual patients and to readings from reference quality invasive blood analysis devices... Read more

Arrowhead Research Corporation Acquires Roche RNA Assets and Site in Wisconsin

"This acquisition is transformational for us and important to the broader RNAi field," said Dr. Christopher Anzalone, President and CEO of the Pasadena-based Arrowhead. "The combination of these assets and Arrowhead's existing RNAi technologies results in what we believe to be the broadest RNAi therapeutics company in the world, with unparalleled delivery solutions and licenses granting broad freedom to operate within the three primary siRNA formats" ... Read more

Amgen Appoints Anthony (Tony) Hooper Executive Vice President Global Commercial Operations

Hooper, 56, joins Amgen after sixteen years at Bristol-Myers Squibb Company (BMS) where he was most recently senior vice president, Commercial Operations and president, United States, Japan and Intercontinental. Hooper's broad commercial operations experience includes running the BMS commercial business in North America, Asia, Middle East, Africa, South America and Europe.... Read more

C3 Jian (Inglewood)

• Associate Accountant
• Associate Chemist
• Laboratory Assistant

Keck Graduate Institute (Claremont)

• Director of Career Services  

Nanogea (Culver City)

• Scientist

Neomend (Irvine)

• Principal Mechanical Engineer 

Replenish (Pasadena)

• Test Engineer 
• Administrative Assistant 
• CAD Product Developer 

Boston Scientific Neuromodulation (Valencia)

• Strategic Marketing Mgr 
• Sr Product Mgr DBS 
• Sr Product Mgr 
• Marketing Communication Mgr 

Kinamed (Camarillo)

•  International Regulatory Affairs Associate 

•  Entry-Level Marketing 

•  Western Region Sales Manager